# Long-acting G-CSF for Febrile Neutropenia

> **NCT03740464** · PHASE3 · UNKNOWN · sponsor: **Lei Li** · enrollment: 556 (estimated)

## Conditions studied

- Epithelial Ovarian Cancer
- Colony Stimulating Factors
- Febrile Neutropenia
- Myelosuppression Adult
- Adverse Event
- Cost-effectiveness

## Interventions

- **DRUG:** long-acting granulocyte colony stimulating factor
- **DRUG:** Short-term granulocyte colony stimulating factor

## Key facts

- **NCT ID:** NCT03740464
- **Lead sponsor:** Lei Li
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-10
- **Primary completion:** 2019-11-10
- **Final completion:** 2023-11-10
- **Target enrollment:** 556 (ESTIMATED)
- **Last updated:** 2018-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03740464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03740464, "Long-acting G-CSF for Febrile Neutropenia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03740464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*